Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.

Background: There is a high incidence of opportunistic infection among HIV-1-infected patients with tuberculosis in Africa and, consequently, high mortality. We assessed the safety and efficacy of trimethoprim-sulphamethoxazole 800 mg/160 mg (co-trimoxazole) prophylaxis in prevention of such infecti...

Full description

Bibliographic Details

Published in:	Lancet Vol. 353; no. 9163; pp. 1469 - 1476
Main Authors:	Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, Djomand G, Ackah A, Domoua K, Kadio A, Yapi A, Combe P, Tossou O, Roels TH, Lackritz EM, Coulibaly D, De Cock JM, Coulibaly I, Greenberg AE, Wiktor, S Z
Format:	research tables/charts randomized controlled trial Journal Article
Published:	Lancet 5/1/1999
Online Access:	View this record in EBSCOhost